CBD (cannabidiol) consumer health products are gaining popularity globally. The market has reported astounding growth in the sale, distribution, and consumption among their products designed for health and wellness. In 2022, the market size was valued at approximately $9.31 billion. It experienced growth to $10.77 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 15.78%, reaching around $30.07 billion by 2030.

The products are known for managing pain, reducing stress and anxiety, and improving sleep quality. This surge in popularity is attributed to growing awareness of CBD’s therapeutic benefits and the easing of regulations surrounding hemp cultivation and production. These developments have facilitated increased production and availability of CBD health products globally.

Despite challenges in the market, such as high product cost and inconsistency with regulation, the ongoing clinical research into CBD’s efficacy in treating various conditions, coupled with investments from both private and public sectors in the CBD trade, signals promising growth prospects for the market.

In the Americas, specifically, there is reported rapid growth in this market, propelled by the legalization of cannabis, advancements in CBD health products, and heightened consumer awareness of CBD’s health benefits. In Canada, regulatory adjustments by Health Canada to ease access to cannabis-infused products reflect a growing consumer interest in CBD for wellness.

The EMEA (Europe, Middle East, and Africa) region is also seeing an expansion in the CBD health market, driven by increased clinical research on CBD for treating conditions like anxiety, pain, and sleep disorders. Meanwhile, the Asia-Pacific region is emerging as a significant market, buoyed by the booming nutraceutical and skincare industries and growing investments in oncology-focused CBD research.